We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rua Life Sciences Plc | LSE:RUA | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.75 | 10.50 | 11.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 2.18M | -2M | -0.0323 | -3.33 | 6.67M |
TIDMAOR
RNS Number : 1073A
AorTech International PLC
24 September 2015
AorTech International plc
(the "Company")
Result of AGM and Share Capital Reorganisation
AorTech International plc (AIM: AOR), the biomaterials and medical device IP company, is pleased to announce that at the Annual General Meeting held today, all the resolutions were duly passed.
Accordingly, the proposed share consolidation of the Company's share capital ("Share Capital Reorganisation") will become effective on the record date, being 6.00 p.m. today, 24 September 2015.
Under the Share Capital Reorganisation each of the ordinary shares of 250 pence each in the capital of the Company ("the Existing Ordinary Shares") which at 6pm on 24 September 2015 are shown in the books of the Company to be in issue shall be sub-divided into one new ordinary share of 5 pence in the capital of the Company (each a "New Ordinary Share") and one new deferred share of 245 pence in the capital of the Company (each a "Deferred Share"), such shares having the rights and being subject to the restrictions set out in the Company's articles of association.
Application has been made for the 4,832,778 New Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence at 8.00 a.m. on 25 September 2015 with the existing ISIN GB0033360586.
Following the Share Capital Reorganisation there will be 4,832,778 New Ordinary Shares in issue. The Company does not hold any shares in treasury. Therefore the total number of shares with voting rights in the Company following Admission will be 4,832,778. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.
This information is provided by RNS
For further information contact:
AorTech International plc
Eddie McDaid, Chief Executive Tel: +44 (0)7802 920869
AorTech International plc
Bill Brown, Chairman Tel: +44 (0)7730 718296
finnCap Limited
Jonny Franklin-Adams/ Giles Rolls Tel: +44 20 7220 0500
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSEEFFLFISESU
(END) Dow Jones Newswires
September 24, 2015 07:05 ET (11:05 GMT)
1 Year Rua Life Sciences Chart |
1 Month Rua Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions